Tag: precision oncology market growth

  • Global Precision Oncology Market Projected to Expand at 10.6% CAGR by 2029

    Global Precision Oncology Market Projected to Expand at 10.6% CAGR by 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    How Much Was The Precision Oncology Market Worth In 2025, And What Is Its Anticipated Value By 2029?

    The precision oncology market has seen rapid expansion in recent years. It is forecast to increase from $95.73 billion in 2024 to $106.21 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.0%. This market’s historical growth can be attributed to an increasing number of companion diagnostics receiving approval, a heightened focus on biomarker discovery and validation, rising investments in oncology research and innovation, an expansion in precision oncology clinical trials, and a growing preference for minimally invasive diagnostic techniques.

    The precision oncology market is poised for significant expansion over the coming years. Its valuation is projected to reach $158.90 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.6%. This anticipated growth during the forecast period stems from factors such as the increasing incidence of cancer, the growing acceptance of genomics-based diagnostic tools, heightened awareness among both patients and medical professionals, the expanded use of next-generation sequencing, and the escalating need for targeted cancer treatments. Key trends anticipated for the forecast period encompass advancements in liquid biopsy technologies, the sophisticated application of single-cell sequencing for tumor examination, the creation of decentralized testing platforms, pioneering work in radiogenomics for treatment strategy, and progress in developing patient-specific cancer vaccines.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

    What Are The Top Growth Drivers Impacting The Precision Oncology Market Outlook?

    Growing recognition and a move towards personalized treatments are anticipated to fuel the expansion of the precision oncology market in the future. These therapies are tailored medical interventions, crafted based on a person’s unique genetic profile, biological markers, and particular disease features, with the aim of boosting efficacy and minimizing adverse reactions. The rise of personalized therapies is attributed to progress in genomic technologies, which facilitate the accurate detection of mutations that drive diseases, leading to more potent and focused therapeutic approaches. Precision oncology contributes to the advancement of personalized therapies by employing genomic and molecular profiling to customize cancer treatments according to the unique genetic composition of a patient’s tumor. As an illustration, in February 2023, GOV.UK, a government department based in the UK, reported that the Health and Social Care Secretary had signed a Memorandum of Understanding with BioNTech SE. This agreement aims to further cancer vaccine research in England, with a target of providing 10,000 personalized therapy doses to UK patients by 2030. Consequently, the growing recognition and adoption of personalized therapies are propelling the expansion of the precision oncology market.

    What Are The Major Segment Types Covered In The Precision Oncology Market?

    The precision oncology market covered in this report is segmented

    1) By Type: Genomic Sequencing, Immunotherapy

    2) By Product Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

    3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

    4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

    5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

    Subsegments:

    1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

    2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

    What Trends Are Redefining The Precision Oncology Market Dynamics?

    Leading companies operating in the precision oncology market are concentrating on developing novel approaches, such as the molecular tumor board, to support individualized treatment decisions by integrating genomic information with clinical context. A molecular tumor board is a dedicated panel of specialists that analyzes and interprets complex genomic and molecular test data to guide precision-driven cancer therapies tailored to the specific tumor characteristics of individual patients. For instance, in December 2024, Aster DM Healthcare Ltd., a UAE-based healthcare provider, launched a precision oncology clinic as part of three personalized cancer care initiatives designed to transform treatment through data-driven, genomic-focused strategies. This clinic delivers customized cancer therapy based on each patient’s tumor genetic profile, enabling more precise, effective treatments with reduced side effects. This approach enhances treatment outcomes, minimizes toxicity, and improves quality of life by aligning therapies to the unique molecular features of a patient’s cancer.

    Which Leading Companies Dominate The Precision Oncology Market Share?

    Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Eli Lilly and Company, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

    Which Regional Markets Are Contributing Most To The Precision Oncology Industry Expansion?

    North America was the largest region in the precision oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Precision Oncology Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=27395&type=smp

    Browse Through More Reports Similar to the Global Precision Oncology Market 2025, By The Business Research Company

    Precast Concrete Market 2025

    https://www.thebusinessresearchcompany.com/report/precast-concrete-market

    Boiler Tank And Shipping Container Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

    Drill Pipe Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Strategic Report on Precision Oncology Market: Growth Opportunities and Emerging Challenges

    Strategic Report on Precision Oncology Market: Growth Opportunities and Emerging Challenges

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Much Is the Global Precision Oncology Market Valued at Present and by 2029?

    In the past few years, the size of the precision oncology market has witnessed rapid expansion. The market, estimated at $95.73 billion in 2024, is anticipated to escalate to $106.21 billion in 2025, with a compound annual growth rate (CAGR) of 11.0%. Factors contributing to growth during the historic phase include an increase in the approval of companion diagnostics, emphasis on the discovery and validation of biomarkers, growth in funding for oncology research and innovation, a higher number of clinical trials related to precision oncology, and an increased inclination towards less invasive diagnostic methods.

    In the coming years, the precision oncology market is projected to witness substantial growth, with its size anticipated to reach $158.90 billion by 2029, progressing at a compound annual growth rate (CAGR) of 10.6%. Factors contributing to this predicted growth during the forecast period include the rising number of cancer cases, the surging acceptance of genomics-based diagnostics, increased awareness among patients and medical professionals, the expanding use of next-generation sequencing and the growing need for targeted cancer treatments. Key trends for the forecast period are advancements in liquid biopsy technologies, the sophisticated use of single-cell sequencing in tumour analysis, the creation of decentralized testing platforms, innovations in radio genomics for treatment planning and progress in personalised cancer vaccines.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

    #What Drivers Are Influencing Growth In The Precision Oncology Market?

    The growth of the precision oncology market is anticipated to surge due to the escalating comprehension and transition towards personalized therapies. These therapies are designed to fit a person’s genomic structure, biomarkers, and particular disease traits to amplify their efficacy and minimize their side effects. Progressions in genomic technologies are fostering the augmentation of personalized therapies by enabling the exact detection of mutations that cause diseases, which further permits the development of more successful and targeted treatments. Precision oncology bolsters personalized therapies through the utilization of genomic and molecular profiling, thereby calibrating cancer treatment to conform to a patient’s specific tumor genetics. As an example, according to GOV.UK, in February 2023, the Health and Social Care Secretary from a UK-based government bureau inked a Memorandum of Understanding (MoU) with BioNTech SE to boost cancer vaccine research in England with the goal to provide 10,000 personalized therapy doses to patients in the UK by 2030. Hence, the mounting comprehension and transition towards personalized therapies are propelling the expansion of the precision oncology market.

    What Are The Main Segments Identified In The Precision Oncology Market Research?

    The precision oncology market covered in this report is segmented

    1) By Type: Genomic Sequencing, Immunotherapy

    2) By Product Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

    3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

    4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

    5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

    Subsegments:

    1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

    2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

    What Are The Leading Trends And Opportunities In The Precision Oncology Sector?

    Leading firms in the precision oncology market are utilizing inventive strategies, such as the molecular tumor board, to facilitate bespoke treatment decisions—melding genomic data with clinical context. The molecular tumor board is essentially a group of specialists tasked with examining and interpreting intricate genomic and molecular test results to provide precision-guided cancer treatments tailored to each patient’s specific tumor traits. For example, in December 2024, Aster DM Healthcare Ltd., a healthcare provider in the UAE, launched a precision oncology clinic as part of three personalized cancer care initiatives aimed at revolutionizing treatment using data-driven, genomic-centric methods. This clinic offers tailored cancer treatments derived from the patient’s tumor genetic makeup, allowing for more accurate and potent therapies with fewer side effects. This strategy boosts treatment success rates, reduces toxicity, and enhances the patient’s quality of life by tailoring treatments to the unique molecular attributes of an individual’s cancer.

    Which Companies Play A Key Role In The Development Of The Precision Oncology Market?

    Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Eli Lilly and Company, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

    What Are The Key Regional Developments Shaping The Precision Oncology Market?

    North America was the largest region in the precision oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=27395&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model